ICUCW
Financials
- Market Capitalization 13.6171 M
- Employee 17
- Founded 2007
- CEO N/A
- Website www.seastarmedical.com
- Headquarter Colorado, United States
- FIGI BBG00YVJVRK3
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 7358 |  BIVIW BioVie Inc. - Warrant | 0.3200 USD | -4.48% | +23.08% | -15.79% | -16.01% | 16.29 M USD | ||
| 7362 |  NRSNW NeuroSense Therapeutics Ltd. - Warrant | 0.0700 USD | 0.00% | +78.57% | -29.58% | -88.80% | 13.67 M USD | ||
| 7367 |  ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0150 USD | +6.38% | +15.38% | -37.50% | -63.41% | 11.94 M USD | ||
| 7389 |  CDIOW Cardio Diagnostics Holdings Inc. - Warrant | 0.0167 USD | -0.60% | +18.44% | +60.58% | -20.48% | 5.48 M USD |
Frequently asked questions about SeaStar Medical Holding Corporation Common Stock
What is the SeaStar Medical Holding Corporation Common Stock stock price today?
The current price of SeaStar Medical Holding Corporation Common Stock (ICUCW) is 0.0176. Over the past 24 hours, the stock has changed by +1.73%. Follow the ICUCW chart for real-time price dynamics.
What is the stock ticker of SeaStar Medical Holding Corporation Common Stock?
SeaStar Medical Holding Corporation Common Stock trades under the ticker ICUCW. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is SeaStar Medical Holding Corporation Common Stock stock going up?
ICUCW has changed by +1.15% over the last week, -11.56% over the last month, and -64.80% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of SeaStar Medical Holding Corporation Common Stock?
SeaStar Medical Holding Corporation Common Stock currently has a market capitalization of 13.62 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were SeaStar Medical Holding Corporation Common Stock earnings last quarter?
Last quarter, SeaStar Medical Holding Corporation Common Stock reported earnings of -0.91 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was SeaStar Medical Holding Corporation Common Stock revenue for the last quarter?
SeaStar Medical Holding Corporation Common Stock reported quarterly revenue of 615 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was SeaStar Medical Holding Corporation Common Stock net income for the last quarter?
SeaStar Medical Holding Corporation Common Stock reported net income of -3.73 M for the last quarter. The previous quarter showed -3.52 M, which means net income changed by -5.94%.
How many employees does SeaStar Medical Holding Corporation Common Stock have?
As of the latest available data, SeaStar Medical Holding Corporation Common Stock has 17 employees. Workforce size can provide additional context about the company's scale and operations.
What is SeaStar Medical Holding Corporation Common Stock EBITDA?
SeaStar Medical Holding Corporation Common Stock EBITDA is -3.78 M, and its EBITDA margin is -615.12%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy SeaStar Medical Holding Corporation Common Stock stock?
You can buy SeaStar Medical Holding Corporation Common Stock (ICUCW) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in SeaStar Medical Holding Corporation Common Stock stock?
Investing in SeaStar Medical Holding Corporation Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ICUCW chart and related analysis on metatrader.com as part of your research.